What impact could protein stabilisation have for cancer patients?

The latest episode of the DDW 'In Conversation With' series is available to listen to below.

This week, Bruno Quinney speaks to Anthony Johnson and Matthew Fyfe from Outrun Therapeutics. Outrun is a biotech specialising in protein stabilisation, an approach being applied to treat HPV+ head and neck cancer.

But what does protein stabilisation mean in practice? And what impact could the approach have for cancer patients?

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.